Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.22% |
| 2 | Healthcare | 7.51% |
| 3 | Financials | 7.44% |
| 4 | Industrials | 5.79% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
Biodesix
BDSX
$236M
| $248K | ﹤0.01% |
5,389
-513
| -9% | -$13.9K |
|
5152
CALL
Citizens Financial Group
CFG
$31.1B
| $248K | ﹤0.01% |
6,300
| – | – |
|
|
LNW
5153
DELISTED
Light & Wonder
LNW
| $248K | ﹤0.01% |
4,229
-30,881
| -88% | -$1.77M |
|
5154
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
| $247K | ﹤0.01% |
3,173
-11,186
| -78% | -$873K |
|
5155
Alaunos Therapeutics
TCRT
$4.64M
| $247K | ﹤0.01% |
+2,542
| New | +$368K |
|
|
NIU
5156
Niu Technologies
NIU
$196M
| $246K | ﹤0.01% |
47,030
-8,448
| -15% | -$32.5K |
|
5157
CALL
Dell
DELL
$302B
| $245K | ﹤0.01% |
+6,100
| New | +$241K |
|
|
5158
PUT
Dell
DELL
$302B
| $245K | ﹤0.01% |
+6,100
| New | +$241K |
|
|
SBC
5159
SBC Medical Group
SBC
$324M
| $245K | ﹤0.01% |
+24,000
| New | +$243K |
|
|
BGRY
5160
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $245K | ﹤0.01% |
405,036
+227,229
| +128% | +$254K |
|
|
BIOR
5161
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $244K | ﹤0.01% |
7,418
+3,696
| +99% | +$270K |
|
5162
PUT
STAAR Surgical
STAA
$1.2B
| $243K | ﹤0.01% |
+5,000
| New | +$314K |
|
|
ECDA
5163
DELISTED
ECD Automotive Design
ECDA
| $242K | ﹤0.01% |
+121
| New | +$243K |
|
5164
Hingham Institution for Saving
HIFS
$668M
| $242K | ﹤0.01% |
878
-97
| -10% | -$25.6K |
|
5165
Steven Madden
SHOO
$3.58B
| $242K | ﹤0.01% |
7,564
-1,050,481
| -99% | -$32.9M |
|
|
CLYM
5166
Climb Bio
CLYM
$719M
| $242K | ﹤0.01% |
67,685
-4,380
| -6% | -$13K |
|
|
ADAP
5167
DELISTED
Adaptimmune Therapeutics
ADAP
| $240K | ﹤0.01% |
164,659
+153,255
| +1,344% | +$248K |
|
|
AKYA
5168
DELISTED
Akoya BioSciences
AKYA
| $240K | ﹤0.01% |
25,084
-215,149
| -90% | -$2.65M |
|
5169
Levi Strauss
LEVI
$9.43B
| $240K | ﹤0.01% |
15,470
-1,661,896
| -99% | -$25.8M |
|
5170
Latham Group
SWIM
$669M
| $240K | ﹤0.01% |
74,570
-1,077,878
| -94% | -$3.89M |
|
|
AUTL
5171
Autolus Therapeutics
AUTL
$519M
| $239K | ﹤0.01% |
125,650
+46,640
| +59% | +$118K |
|
5172
Landmark Bancorp
LARK
$191M
| $239K | ﹤0.01% |
12,218
-2,336
| -16% | -$48.5K |
|
|
NSTG
5173
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $239K | ﹤0.01% |
+30,000
| New | +$260K |
|
5174
First Northwest Bancorp
FNWB
$107M
| $238K | ﹤0.01% |
15,490
-4,761
| -24% | -$72K |
|
5175
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $238K | ﹤0.01% |
4,782
-1,394
| -23% | -$69K |
|
Similar funds
Millennium Management's Q4 2022 Portfolio in Review
As of Q4 2022, Millennium Management held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management's Q4 2022 filing shows 848 new, 2,517 increased, 2,492 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Millennium Management added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Millennium Management's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Millennium Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Millennium Management's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Millennium Management opened 848 new positions and closed 1,332 in Q4 2022.
- Millennium Management's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.